Using AI, we accelerate the development of new medicinal products in the area of oncology.
Dear customer, we are sorry but your browser doesn't support all necessary features for good site view. Please switch to one of the modern browsers (Chrome, Safari, Firefox).
AI and biotechnology in medicine
Development of medicines
We are working together with the pharmaceutical industry in the early stages of drug research. We apply our own artificial intelligence algorithms in the search for molecules suitable for use in the development of immunotherapies for cancer patients.
By using domain-specific AI models in new context an situations, we achieve unique results. In researching the potential of individual molecules for cancer treatments, we successfully use, for example, the word2vec technique originally designed for natural language processing.
“Biotechnology development is extremely costly in terms of resources and time. Together with Dataclair AI we are testing a project in which AI is providing a significant boost to efficiency in one area of basic research. Thanks to the results of this we can rapidly identify important information and promising directions for future work in the development of cancer treatment.”
